PTC Therapeutics PTCT Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's pre-tax income?
- PTC Therapeutics (PTCT) reported pre-tax income of -$2.46M in Q1 2026.
- How has PTC Therapeutics's pre-tax income changed year-over-year?
- PTC Therapeutics's pre-tax income decreased by 100.3% year-over-year, from $929.83M to -$2.46M.
- What is the long-term trend for PTC Therapeutics's pre-tax income?
- Over 3 years (2021 to 2024), PTC Therapeutics's pre-tax income has grown at a -11.2% compound annual growth rate (CAGR), from -$518.34M to -$363.12M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.